[1. Gibson Ch, Berliner N. How we evaluate and treat neutropenia in adults. Blood. 2014; 124 (8):1251-1258.10.1182/blood-2014-02-48261224869938]Search in Google Scholar
[2. Newburger P, Dale D. Evaluation and management of patients with isolated neutropenia. Semin Hematol. 2013; 50 (3): 198-206.10.1053/j.seminhematol.2013.06.010374838523953336]Open DOISearch in Google Scholar
[3. Gołąb J., Jakóbisiak M. Rozpoznanie drobnoustrojów przez nieswoiste mechanizmy odporności. [w:] Gołąb J, Jakóbsiak M, Lasek W i wsp., red. Immunologia. Nowe wydanie. Warszawa: PWN; 2014, s.234-235.]Search in Google Scholar
[4. Kabata J, Hellman A. Choroby układu krwiotwórczego. Badania laboratoryjne i morfologiczne, [w:] Gajewski P, Interna Szczeklik. Podręcznik chorób wewnętrznych 2014. Medycyna Praktyczna. Kraków; 2014, s. 1578-1579.]Search in Google Scholar
[5. Boxer L. How to approach neutropenia. ASH Education Book. 2012; (1): 174-182.10.1182/asheducation.V2012.1.174.3798251]Search in Google Scholar
[6. Palmblad J, Nilson Ch, Hoglund P, et al. How we diagnose and treat neutropenia in adults. Expert Rev. Hematol. 2016; 9 (5):479-487.10.1586/17474086.2016.1142867]Search in Google Scholar
[7. http://www.genecards.org/cgi-bin/carddisp.pl?gene=ACKR1, dostęp: 10.08.2017.]Search in Google Scholar
[8. Vandenberghe P, Beel K. Severe congenital neutropenia, a genetically heterogenous disease group with an increased risk of AML/MDS. Pediatr Rep. 2011; 3 (2):e9.10.4081/pr.2011.s2.e9320653722053285]Search in Google Scholar
[9. Rosenberg P, Alter B, Bolyard A. Severe Chronic Neutropenia International Registry. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006; 107 (12):4628-4635.10.1182/blood-2005-11-4370189580416497969]Search in Google Scholar
[10. Mansoor M, Khan M. A case of Cycylic Neutropenia in adults. J Pak Med Assoc. 2012; 62 (3):289-290.]Search in Google Scholar
[11. Huber M, Andersohn F, Bonder E, et al. Drug-induced agranulocytosis in the Berlin case-control surveillance study. Eur J Clin Pharmacol. 2014; 70 (3):339-345.10.1007/s00228-013-1618-124297345]Open DOISearch in Google Scholar
[12. Nakamura H, Miyauchi A, Miyawaki N, et al. Analysis of Antithyroid Drug-Induced Agranulocytosis Over 30 Years in Japan. Eur J Clin Pharmacol. 2014;70 (3):339-345.]Search in Google Scholar
[13. Zhong X, Lim EA, Hershman DL, et al. Identifying Severe Adverse Event Clusters Using the National Cancer Institute’s Common Terminology Criteria for Adverse Events. J Oncol Pract. 2016;12 (3): 245-246.10.1200/JOP.2015.006106570279326907453]Search in Google Scholar
[14. Potemski P. Neutropenia, [w:] Krzakowski M, Warzocha K. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych — 2013. Gdańsk: Via Medica; 2013, s. 537-547]Search in Google Scholar
[15. Kos-Zakrzewska K, Konopka L. Białaczka limfocytowa z dużych ziarnistych limfocytów T. Onkologia Polska. 2009; 12 (2):65-69.]Search in Google Scholar
[16. Robak T. Rzadsze przewlekłe białaczki limfoidalne. Acta Haematologica Polonica. 2011; 42 (3): 343–355.]Search in Google Scholar
[17. Lustberg M. Management of Neutropenia in Cancer Patients. Clin Adv Hematol Oncol. 2012; 12(10): 825–826.]Search in Google Scholar
[18. Hus M. Leczenie wspomagające w chorobach hematologicznych. [w:] Dmoszyńska A, Robak T, Hus I. Podstawy hematologii. Lublin: Czelej; 2015, s.414-422.]Search in Google Scholar
[19. Ebru R, Yalcinkaya-Erdemci Z, Burcak Cehreli S. Oral findings and clinical implications of patients with congenital neutropenia: a literature review. Turk J. Pediatr. 2013; 55 (3): 241-245.]Search in Google Scholar
[20. Rosenberg P, Zeidler C, Bolyard A, et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010; 150 (2):196–199.10.1111/j.1365-2141.2010.08216.x290669320456363]Search in Google Scholar
[21. Rosenberg P, Alter B, Bolyard A, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006; 107 (12): 4628–4635.10.1182/blood-2005-11-4370]Search in Google Scholar
[22. Coughlan M, Healy C. Nursing care, education and support for patients with neutropenia. Nursing standard. 2008; 46 (22): 35-41.10.7748/ns2008.07.22.46.35.c659818712243]Search in Google Scholar